CRISPR Therapeutics stock price target reaffirmed at $80 by Citizens - Investing.com India

Source: Investing.com India · 2026-09-28T09:20:50+00:00

CRISPR Therapeutics stock price target reaffirmed at $80 by Citizens Investing.com India

BestAIBroker analysis

Finance-aware sentiment: neutral (+0.00 on a -1 to +1 scale).
Event classification: OTHER.
Market importance score: 28/100, weighting entity relevance, source credibility, multi-outlet coverage and recency.
Symbols referenced: ACRS, CAPR, CCCC, ACRV, COEPW.